Stefan Doboczky (Austrian) holds a Masters in Chemisty and a PhD in Natural and Technical Science from the University of Vienna and an MBA from IMD in Lausanne.
Prior to joining DSM in 1998 Stefan Doboczky worked for 6 years at ARCO Chemicals in Austria and the UK.
At DSM, Stefan Doboczky started in the DSM Fine Chemicals division, where he became Business Manager. In 2002 he moved to DSM Pharma Chemicals where he was Business Director from 2003 till 2006 based in the Netherlands. In 2006 he became Vice President and Business Unit Director China for DSM Anti-Infectives based in China. Since 2009 he has been Business Group Director of DSM Anti-Infectives. He has built a strong track record within the DSM Pharma cluster and has particular experience setting up new business models within high growth economies.
Since becoming a Member of the Managing Board of Royal DSM in May 2011 he has been responsible for DSM’s global activities in Pharma as well as all DSM’s activities in Asia. He is also CEO of DSM Sinochem Pharmaceutical, a joint venture between DSM and Sinochem in the area of anti-infectives.